OncoNano Medicine, Inc. Email Format

Biotechnology ResearchTexas, United States11-50 Employees

OncoNano Medicine, Inc. is a small biotechnology company focused on oncology research, headquartered in Dallas, Texas. It develops targeted cancer therapies by encapsulating therapeutic payloads in its ON-BOARD polymeric micelle platform, leveraging the acidic tumor microenvironment to promote drug localization at tumor sites. By improving pharmacokinetic and pharmacodynamic properties of payloads—ranging from small molecules to larger biologics—these micelles support localized tumor targeting. The company serves oncology researchers and pharmaceutical developers seeking more precise cancer therapies with improved tumor targeting. It operates as a clinical-stage biotechnology company advancing precision cancer therapies. In January 2026, OncoNano announced a research collaboration with Gilead Sciences to evaluate its ON-BOARD encapsulation technology with a Gilead drug candidate.

Sign up for free to view info

Company overview Employee directory